Society for Research on Nicotine and Tobacco (SRNT 2019)

SRNT’s Annual Meeting provides an excellent opportunity for attendees of all experience levels to participate in the highest caliber of professional programming devoted to research and practice in the field of nicotine and tobacco research. The Annual Meeting includes an education-packed scientific program that allows more than 1,100 international attendees to stay current with the latest breaking research. This year's meeting will be held February 20-23, 2019, at the Hilton San Francisco in San Francisco, California. 

Schedule

21 February

11:30 to 12:00

F Zanetti

Systems Toxicology Assessment of Repeated Exposure of Human Organotypic Gingival Cultures to Swedish Snus Extracts and Total Particulate Matter from Cigarette Smoke

21 February

11:30 to 13:00

A Kuczaj

Interfacial Dynamics of the Model Pulmonary Surfactant in the Presence of Glycerol/ Propylene Glycol Mixtures

21 February

16:30 to 18:00

P Langer

Sociodemographic Characteristics of « Heat-not-Burn » Product Users Comparaed with Cigarette Smokers: First-Year Results of a Repeated Crosssectional Survey Japan

22 February

11:30 to 13:00

S Boue

Biomarker discovery for nicotine–containing product assessment can be facilitated by intervals, a platform to share and analyze nonclinical and clinical data.

22 February

11:30 to 12:00

Loyse Felber Medlin

A Multicenter, Multiregional Study on Biological and Functional Changes in Healthy Adult Smokers during One Year of Continuous Smoking Abstinence

22 February

11:30 to 13:00

C Pater

Cardiovascular Effects Observed When Using the Tobacco Heating System (THS) Compared with Continued Smoking

22 February

11:30 to 13:00

N Lama

Exploring Discriminant Capacity of Urinary CEMA as Combustion marker in Tobacco Users, a Population Pharmacokinetic Approach

22 February

11:30 to 13:00

E Clerc

Creating a repository for the assessment of tobacco-related behavioral outcomes: A case example

22 February

11:30 to 13:00

CT Tran

Decreased Levels of Biomarkers of Exposure in Smokers Switching to Carbon Heated Tobacco Product 1.2: A Randomized, Controlled, Open-Label 90-Day Exposure Study

22 February

11:30 to 13:00

A van der Plas

Impact of Switching to a Heat-not-burn Tobacco Product on CYP1A2 Activity: A Review of Four Clinical Studies

22 February

11:30 to 13:00

S Fredersdorf

Nicotine Pharmacokinetic and Pharmacodynamic Effects of P4M3 Compared With Subjects’ Own Electronic Cigarette

22 February

11:30 to 13:00

M Bosilkovska

Nicotine Pharmacokinetics and Subjective Effects following Use of a Novel Nicotinecontaining Powder Product

22 February

11:30 to 13:00

E. F. Afolalu

Psychometric Validationof the Aboutdependence: A fit-forpurpose Instrument to Assess Global Dependence on Tobacco and Nicotine Products

22 February

16:30 to 18:00

M Hankins

Test-Retest Reliability of the Lifestyle Questionnaire: Post-hoc Analysis of a Smoking Cessation Study

22 February

16:30 to 18:00

E Spies

Differences in Perceived Health Risk of Cigarettes and IQOS by Current Product Use Categories and Intention to Quit: A Cross-Sectional Study in Japan